NPPA Updates Ceiling Price Applicability for Ringer Lactate Non-Glass Packs, Details

Published On 2025-09-10 15:14 GMT | Update On 2025-09-10 15:14 GMT

New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has issued an addendum to its earlier price fixation orders for scheduled formulations of Ringer Lactate (non-glass with special features).

The addendum, dated August 29, 2025, modifies NPPA’s earlier orders S.O. 1474(E) dated March 27, 2025, and S.O. 2998(E) dated July 4, 2025, by adding three manufacturers under Table B for ceiling price applicability.

The notification states:

“Sl. No. 23, 24 and 25 shall be added in Table ‘B’ as below:”

Sl. No.	Name of Manufacturer	Product/ Brand Name
(1)	(2)	(3)
23.	M/s BML Parenteral Drugs (note e2 below)	Euro Head Cap
24.	M/s Hindustan Polyfab (note e3 below)	Euro Head /LDPE Bottles
25.	M/s Pharma Implex Laboratories Pvt. Ltd. (note e4 below)	Euro Cap/Head Bottles

Further clarifications have been issued regarding applicable ceiling prices for these manufacturers:

For M/s BML Parenteral Drugs, only formulations at Sl. No. 2 and 3 of Table A are applicable.

For M/s Hindustan Polyfab, only the formulation at Sl. No. 3 of Table A is applicable.

For M/s Pharma Implex Laboratories Pvt. Ltd., only formulations at Sl. No. 3 and 4 of Table A are applicable.

The addendum has been published in the Gazette of India as notification S.O. 3978(E), with Dy. Director Mahaveer Saini signing the order.

To view the official notification, click on the link below:

https://medicaldialogues.in/pdf_upload/80afc3083c99c6700f437c4a0fdcc30c-300118.pdf

Also Read: NPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, Cefixime

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Parthika Patel

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

NPPA Updates Ceiling Price Applicability for Ringer Lactate Non-Glass Packs, Details

Similar News

CDSCO Criminal Prosecution Against IndiaMART Put on Hold by Delhi HC Till Sept 17

Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA

CDSCO Eases Rules for Biopharma Research, Will Accept Lab Biosafety Committee Approvals

41 Pharmacies in Delhi Caught Illegally Selling Abortion Pills Mifepristone, Misoprostol

Visakhapatnam Pharma Plant Gas Leak Claims Chemist's Life, CITU Alleges Negligence

Torrent Pharma to acquire 26% stake in Torrent Urja 27 for captive renewable power project

Sanofi Tzield approved in China for adult, pediatric patients with stage 2 type 1 diabetes